-+ 0.00%
-+ 0.00%
-+ 0.00%

LYELL IMMUNOPHARMA PRESENTS NEW CLINICAL DATA FROM ONGOING TRIAL OF RONDE-CEL SHOWING HIGH RATES OF DURABLE COMPLETE RESPONSES IN PATIENTS WITH LARGE B-CELL LYMPHOMA AT THE 67TH ASH ANNUAL MEETING AND EXPOSITION

Reuters·12/07/2025 21:30:00

Please log in to view news